Browsing Centre for Biochemical Pharmacology by Author "Tohda, Y"
Now showing items 1-4 of 4
-
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
Pfeffer, PE; Ali, N; Murray, R; Ulrik., C; Tran, TN; Maspero, J; Peters, M; Christoff, GC; Sadatsafavi, M; Torres-Duque, CA (2023) -
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both
Price, D; pfeffer, P; Ali, N; Murray, R; Ulrik, C; Tran, T; Maspero, J; Peters, M; Christoff, G; Sadatsafavi, M (2022) -
Eosinophilic and non-eosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort.
Heaney, LG; Perez de Llano, L; Al-Ahmad, M; Backer, V; Busby, J; Canonica, GW; Christoff, GC; Cosio, BG; FitzGerald, JM; Heffler, E (2021-04-19)BACKGROUND: Phenotypic characteristics of eosinophilic and non-eosinophilic asthma patients are not well-characterized in global, real life severe asthma cohorts. RESEARCH QUESTION: What is the prevalence of eosinophilic ... -
International severe asthma registry (ISAR): protocol for a global registry
FitzGerald, JM; Tran, TN; Alacqua, M; Altraja, A; Backer, V; Bjermer, L; Bjornsdottir, U; Bourdin, A; Brusselle, G; Bulathsinhala, L (BioMed Central, 2020-08-14)